|View printer-friendly version|
|October 17, 2003 4:47 p.m.|
|Teva Announces Tentative Approval for Gabapentin Tablets, 600 Mg and 800 Mg|
Jerusalem, Israel, October 17, 2003 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U. S. Food and Drug Administration has granted tentative approval for the company's ANDA for Gabapentin Tablets, 600 mg and 800 mg. Annual sales of the brand product are approximately $662 million.